on 14 Nov 2017
Last Applicant/ Owned by
60 L Avenue du 14 juillet
CHENOVE
FR
F21300
Serial Number
79204399 filed on 30th Nov 2016
Registration Number
5332151 registered on 14th Nov 2017
Correspondent Address
Brooks R. Bruneau
Filing Basis
No Filing Basis
Disclaimer
"SUMATRIPTAN"
The mark consists of the wording, "ZEPZUMA SUMATRIPTAN" in a stylized font. The "ZEP" appears in a gray font, while "ZUMA" is in black. "SUMATRIPTAN" appears in a light blue, lower case font. In the top right corner is a light blue circle with a four pointed green star in it, outlined in white. All other instances of white in the mark are for background purposes only, and are not claimed as a featRead More
Pharmaceutical products, namely, pharmaceutical preparations based on Sumatriptan for the treatment of migraines and cluster headaches
No 79204399
No Service/Collective Mark
No 04774.T665US
No
No
No
No
No
No
No
No
01.01.02 -
A single star with four points
26.01.21 -
Circles that are totally or partially shaded
The mark consists of the wording, "ZEPZUMA SUMATRIPTAN" in a stylized font. The "ZEP" appears in a gray font, while "ZUMA" is in black. "SUMATRIPTAN" appears in a light blue, lower case font. In the top right corner is a light blue circle with a four pointed green star in it, outlined in white. All other instances of white in the mark are for background purposes only, and are not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 14th Nov 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 13th Apr 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st Feb 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| 21st Feb 2018 | FINAL DISPOSITION PROCESSED |
| 14th Feb 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 14th Nov 2017 | REGISTERED-PRINCIPAL REGISTER |
| 29th Aug 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Aug 2017 | PUBLISHED FOR OPPOSITION |
| 09th Aug 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Jul 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
